-
公开(公告)号:WO2016128541A1
公开(公告)日:2016-08-18
申请号:PCT/EP2016/052990
申请日:2016-02-12
发明人: MEYERHANS, Andreas , MARTINEZ DE LA SIERRA, Miguel-Angel , BRAI, Annalaura , FAZI, Roberta , TINTORI, Cristina , BOTTA, Maurizio , ARAQUE, José-Esté , MARTINEZ, Javier
IPC分类号: C07D401/12 , C07D405/12 , C07D249/04 , C07D249/06 , C07D257/04 , C07D271/06 , C07D271/10 , A61P31/12 , A61K31/4192 , A61K31/433 , A61K31/4245 , A61K31/41 , A61K31/4725 , A61K31/4439 , C07D261/08 , C07D285/12
CPC分类号: C07D249/06 , A61K31/4192 , A61K31/42 , A61K31/4245 , A61K31/433 , A61K31/4439 , A61K31/496 , A61K31/5377 , A61K31/675 , A61K31/7056 , A61K45/06 , C07D249/04 , C07D257/04 , C07D261/08 , C07D271/06 , C07D271/10 , C07D285/12 , C07D401/04 , C07D401/12 , C07D405/12 , C07F9/65182 , C07H15/18
摘要: The present invention refers to compounds endowed with RNA helicase DDX3 inhibitory activity of formula I and II and their therapeutic use, in particular for the treatment of viral diseases.
摘要翻译: 本发明涉及具有式I和II的RNA解旋酶DDX3抑制活性的化合物及其治疗用途,特别是用于治疗病毒性疾病。
-
公开(公告)号:WO2017162834A1
公开(公告)日:2017-09-28
申请号:PCT/EP2017/057010
申请日:2017-03-23
IPC分类号: A61K31/41 , A61K31/4192 , A61K31/497 , A61K31/5377 , A61K31/4196 , A61K31/42 , A61K31/4245 , A61K31/433 , A61K31/675 , A61K31/7056 , A61P35/00 , A61K31/18
摘要: The present invention refers to compounds of formula I or II endowed with DDX3 inhibitory activity, relative pharmaceutical compositions and their use as antihyperproliferative agents. (I) or (II)
摘要翻译: 本发明涉及具有DDX3抑制活性的式I或II化合物,相对药物组合物及其作为抗高增殖剂的用途。 (I)或(II) p>
-